Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma

European Journal of Haematology

Volumn 80, Issue 1, 2008, Pages 61-66

  Kastrup, Ingelise Bjerring ^b   Worm, Jesper ^b   Ralfkiaer, Elisabeth ^a   Hokland, Peter ^c   Guldberg, Per ^b   Grønbæk, Kirsten ^a,b  

^a Rigshospitalet   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Lymphoma; Methotrexate resistance; Promoter methylation; Reduced folate carrier

Indexed keywords

ANTHRACYCLINE DERIVATIVE; METHOTREXATE; REDUCED FOLATE CARRIER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CHILD; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE MUTATION; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA CELL LINE; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROMOTER REGION;

ADOLESCENT; ADULT; BIOPSY; CHILD; CHILD, PRESCHOOL; CODON, NONSENSE; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, NEOPLASM; EPIGENESIS, GENETIC; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; POINT MUTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS (GENETICS);

EID: 37249089438     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00980.x     Document Type: Article

References (33)

1. Cook R. Folate metabolism. In : Carmel R, Jacobsen DW, eds. Homocysteine in Health and Disease. Cambridge : Cambridge University Press, 2001 : 113 34.
2. Sirotnak FM, Tolner B. Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr 1999 19 : 91 122.
3. Zhao R, Goldman ID. Resistance to antifolates. Oncogene 2003 22 : 7431 57.
4. Gorlick R, Goker E, Trippett T, Steinherz P, Elisseyeff Y, Mazumdar M, Flintoff WF, Bertino JR. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood 1997 89 : 1013 8.
5. Yang R, Sowers R, Mazza B, et al. Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples. Clin Cancer Res 2003 9 : 837 44.
6. Flintoff WF, Sadlish H, Gorlick R, Yang R, Williams FM. Functional analysis of altered reduced folate carrier sequence changes identified in osteosarcomas. Biochim Biophys Acta 2004 1690 : 110 7.
7. Worm J, Kirkin AF, Dzhandzhugazyan KN, Guldberg P. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate- resistant human breast cancer cells. J Biol Chem 2001a 276 : 39990 40000.
8. Wang ES, O'Connor O, She Y, Zelenetz AD, Sirotnak FM, Moore MA. Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression. Leuk Lymphoma 2003 44 : 1027 35.
9. Matsuo K, Suzuki R, Hamajima N, et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001 97 : 3205 9.
10. Lightfoot TJ, Skibola CF, Willett EV, Skibola DR, Allan JM, Coppede F, Adamson PJ, Morgan GJ, Roman E, Smith MT. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 2005 14 : 2999 3003.
11. Skibola CF, Forrest MS, Coppede F, Agana L, Hubbard A, Smith MT, Bracci PM, Holly EA. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004 104 : 2155 62.
12. Gemmati D, Ongaro A, Tognazzo S, et al. Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival. Haematologica 2007 92 : 478 85.
13. Lim U, Wang SS, Hartge P, et al. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 2007 109 : 3050 9.
14. Beckwith M, Longo DL, O'Connell CD, Moratz CM, Urba WJ. Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines. J Natl Cancer Inst 1990 82 : 501 9.
15. World Health Organisation Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In : Jaffe ES, Harris NL, Stein H, et al., eds. Lyon : IARC Press, 2001 171 8.
16. Zhang L, Wong SC, Matherly LH. Structure and organization of the human reduced folate carrier gene. Biochim Biophys Acta 1998 1442 : 389 93.
17. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996 93 : 9821 6.
18. Worm J, Aggerholm A, Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem 2001b 47 : 1183 9.
19. Guldberg P, Worm J, Grønbæk K. Profiling DNA methylation by melting analysis. Methods 2002 27 : 121 7.
20. INK4B methylation in acute myeloid leukemia. Cancer Res 1999 59 : 436 41.
21. Cameron EE, Baylin SB, Herman JG. p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 1999 94 : 2445 51.
22. Melki JR, Vincent PC, Clark SJ. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999 59 : 3730 40.
23. Ge Y, Haska CL, LaFiura K, Devidas M, Linda SB, Liu M, Thomas R, Taub JW, Matherly LH. Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Clin Cancer Res 2007 13 : 451 7.
24. Liu M, Ge Y, Payton SG, Aboukameel A, Buck S, Flatley RM, Haska C, Mohammad R, Taub JW, Matherly LH. Transcriptional regulation of the human reduced folate carrier in childhood acute lymphoblastic leukemia cells. Clin Cancer Res 2006a 12 : 608 16.
25. Ferguson PL, Flintoff WF. Topological and functional analysis of the human reduced folate carrier by hemagglutinin epitope insertion. J Biol Chem 1999 274 : 16269 78.
26. Kaufman Y, Drori S, Cole PD, et al. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia. Cancer 2004 100 : 773 82.
27. Whetstine JR, Gifford AJ, Witt T, Liu XY, Flatley RM, Norris M, Haber M, Taub JW, Ravindranath Y, Matherly LH. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res 2001 7 : 3416 22.
28. Ferreri AJ, Dell'Oro S, Capello D, et al. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. Br J Haematol 2004 126 : 657 64.
29. Eichholzer M, Luthy J, Moser U, Fowler B. Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence. Swiss Med Wkly 2001 131 : 539 49.
30. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002 132 : 2350S 5S.
31. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002 21 : 5400 13.
32. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003 300 : 489 92.
33. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997 94 : 3290 5.